Method for Isolating Extracellular Vesicles from Human Neural Stem Cells Expanded Under Neurosphere Culture

Area of Science:

• Neuroscience
• Cell Biology
• Biotechnology

Background:

• Neural stem cells (NSCs) transplantation shows therapeutic potential for neurological diseases by replacing cells and secreting bioactive molecules.
• Extracellular vesicles (EVs), containing various biomolecules, are key mediators of NSC therapeutic effects.
• Non-cell-based therapies using EVs are gaining traction, necessitating scalable production methods.

Purpose of the Study:

• To develop an efficient method for large-scale production of extracellular vesicles (EVs) from human neural stem cells (NSCs).
• To enable the clinical application of NSC-derived EVs as a therapeutic agent for neurological disorders.

Main Methods:

• Human NSCs were expanded using a free-floating neurosphere assay culture system.
• The neurosphere assay was implemented in bioreactors under Good Manufacturing Practice (GMP)-compliant conditions.
• Extracellular vesicles (EVs) were harvested from the cultured NSCs.

Main Results:

• The described method efficiently yields a significant quantity of EVs from human NSCs.
• Scalable production of neural stem cell-derived EVs (NSC-EVs) is achievable under GMP conditions.
• The produced NSC-EVs are suitable for potential human clinical trials.

Conclusions:

• A scalable and efficient method for producing therapeutic extracellular vesicles (EVs) from neural stem cells (NSCs) has been established.
• This GMP-compliant approach using neurosphere culture in bioreactors facilitates the clinical translation of NSC-EVs.
• This advancement supports the development of novel non-cell-based therapies for neurological diseases.